Patients at High Risk of Cerebrovascular Disease: The REACH Study
Patients at High Risk of Cerebrovascular Disease: The REACH Study
复制标题
DOI：
10.1159/000200443
复制
发表时间：
2009-01-01
影响因子：
2.9
通讯作者：
Lahoz, Carlos
中科院分区：
文献类型：
--
作者：
Mostaza, Jose M.;Martin-Jadraque, Raquel;Lahoz, Carlos
脑血管疾病是发达国家发病率和死亡率的主要原因之一。查明有风险的个人是一个高度优先事项，以便能够实施有效的预防措施。具有最高脑血管疾病风险的受试者是那些已经患有中风或短暂性脑缺血发作的受试者，以及那些在其他区域（冠状动脉或外周动脉）中患有血管疾病的受试者。其他处于风险中的受试者是患有心脏病如心房纤颤的受试者，患有高血压、糖尿病和吸烟习惯的受试者，以及患有亚临床血管疾病的个体。虽然有相当多的证据表明预防性治疗在这一人群中的疗效，但接受最佳治疗的患者比例远不理想。有必要在民众中实施战略，提高对需要建立健康习惯和适当预防性药物治疗的认识，以减少这种使人衰弱的疾病的发病率。版权所有（C）2009 S. Karger AG，巴塞尔
Cerebrovascular disease is one of the leading causes of morbidity and mortality in developed countries. The identification of at-risk individuals is a high priority so that efficacious preventive measures can be implemented. Subjects with the highest risk of cerebrovascular diseases are those who already have had a stroke or a transient ischemic attack, and those with vascular disease in other territories, either in coronary or peripheral arteries. Other subjects at risk are those with cardiac disease, such as atrial fibrillation, those with hypertension, diabetes and smoking habit, as well as individuals with subclinical vascular disease. Although there is considerable evidence for the efficacy of preventive treatment in this population, the percentage of patients receiving optimum treatment is far from ideal. There is a need to implement strategies in the population directed towards increasing awareness of the need to establish healthy habits and adequate preventive pharmacological treatment that could reduce the incidence of this debilitating disease. Copyright (C) 2009 S. Karger AG, Basel